COVID-19 Prevention: Vaccines and Post-Exposure Prophylaxis

September 2026

Questions will come up about 2026-2027 COVID-19 vaccines and the first ORAL med for post-exposure prophylaxis, ensitrelvir (Xocova).

COVID-19 vaccination remains the best tool we have to reduce the risk of severe disease, long COVID-19, hospitalization, and death.

If your hospital stocks COVID-19 vaccines, expect monovalent products again this season...all updated to target the JN.1 lineage XFG variant. Anticipated options include the mRNA vaccines Comirnaty, Spikevax, and mNexspike...and protein-based Nuvaxovid.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote